Press Releases

Company News
Nov 14, 2016
PALATINE, IL -- (Marketwired) -- 11/14/16 -- Acura Pharmaceuticals, Inc. ( NASDAQ : ACUR) , a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for the three and nine months ended September 30, 2016 .
Nov 09, 2016
PALATINE, IL -- (Marketwired) -- 11/09/16 -- Acura Pharmaceuticals, Inc. ( NASDAQ : ACUR) , a specialty pharmaceutical company innovating abuse deterrent drugs , today announced that the Company plans to report financial results for the third quarter 2016 following the close of financial markets on
Aug 08, 2016
PALATINE, IL -- (Marketwired) -- 08/08/16 -- Acura Pharmaceuticals, Inc. ( NASDAQ : ACUR) , a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for the three and six months ended June 30, 2016 . The Company reported a net loss of $3.3 million for
May 02, 2016
PALATINE, IL -- (Marketwired) -- 05/02/16 -- Acura Pharmaceuticals, Inc. ( NASDAQ : ACUR) , a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for the first quarter ended March 31, 2016 . The Company reported net loss of $3.4 million for the first
Apr 21, 2016
PALATINE, IL -- (Marketwired) -- 04/21/16 -- Acura Pharmaceuticals, Inc. ( NASDAQ : ACUR) , a specialty pharmaceutical company innovating abuse deterrent drugs , today announced that the Company plans to report financial results for the first quarter 2016 following the close of financial markets on
Mar 30, 2016
PALATINE, IL -- (Marketwired) -- 03/30/16 -- Acura Pharmaceuticals, Inc. ( NASDAQ : ACUR) today announced that its universal shelf registration statement on Form S-3, as amended, was declared effective by the Securities and Exchange Commission (SEC) today.
Mar 08, 2016
PALATINE, IL -- (Marketwired) -- 03/08/16 -- Acura Pharmaceuticals, Inc. ( NASDAQ : ACUR) , a specialty pharmaceutical company developing products intended to address medication abuse and misuse, today announced that Bob Jones , President and Chief Executive Officer, will present at the 28 th
Feb 29, 2016
PALATINE, IL -- (Marketwired) -- 02/29/16 --  Acura Pharmaceuticals, Inc. ( NASDAQ : ACUR) , a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for the year and three months ended December 31, 2015 .
Feb 22, 2016
PALATINE, IL -- (Marketwired) -- 02/22/16 -- Acura Pharmaceuticals, Inc. ( NASDAQ : ACUR) , a specialty pharmaceutical company innovating abuse deterrent drugs , today announced that the Company plans to report financial results for 2015 following the close of financial markets on Monday, February